196 related articles for article (PubMed ID: 3487319)
21. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
Riachi NJ; Harik SI; Kalaria RN; Sayre LM
J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
[TBL] [Abstract][Full Text] [Related]
22. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
Vyas I; Heikkila RE; Nicklas WJ
J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
[TBL] [Abstract][Full Text] [Related]
23. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
Algeri S; Ambrosio S; Garofalo P; Gerli P
Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of rat brain monoamine oxidase by some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion.
Arai Y; Kinemuchi H; Hamamichi N; Satoh N; Tadano T; Kisara K
Neurosci Lett; 1986 May; 66(1):43-8. PubMed ID: 3487053
[TBL] [Abstract][Full Text] [Related]
25. MPTP, MPP+ and mitochondrial function.
Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE
Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899
[TBL] [Abstract][Full Text] [Related]
26. Pargyline prevents MPTP-induced parkinsonism in primates.
Langston JW; Irwin I; Langston EB; Forno LS
Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
28. Inward transport of 3H-MPP+ in freshly isolated rat hepatocytes: evidence for interaction with catecholamines.
Martel F; Martins MJ; Azevedo I
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):305-11. PubMed ID: 8878060
[TBL] [Abstract][Full Text] [Related]
29. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
Irwin I; Langston JW; DeLanney LE
Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
[TBL] [Abstract][Full Text] [Related]
30. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes.
Scotcher KP; Irwin I; DeLanney LE; Langston JW; Di Monte D
J Neurochem; 1990 Apr; 54(4):1295-301. PubMed ID: 2313288
[TBL] [Abstract][Full Text] [Related]
31. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl.
Fuller RW; Hemrick-Luecke SK
Life Sci; 1986 Nov; 39(18):1645-50. PubMed ID: 3095601
[TBL] [Abstract][Full Text] [Related]
32. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ
Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166
[TBL] [Abstract][Full Text] [Related]
33. Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
Wu EY; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1992 Jul; 262(1):225-30. PubMed ID: 1625201
[TBL] [Abstract][Full Text] [Related]
34. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
[TBL] [Abstract][Full Text] [Related]
35. MPTP-induced ATP depletion and cell death in neuroblastoma X glioma hybrid NG 108-15 cells: protection by glucose and sensitization by tetraphenylborate.
Kutty RK; Santostasi G; Horng J; Krishna G
Toxicol Appl Pharmacol; 1991 Feb; 107(2):377-88. PubMed ID: 1994518
[TBL] [Abstract][Full Text] [Related]
36. Effects of the parkinsonism-inducing neurotoxin MPTP and its metabolite MPP+ on sympathetic adrenergic nerves in mouse iris and atrium.
Luthman J; Jonsson G
Med Biol; 1986; 64(2-3):95-102. PubMed ID: 3489145
[TBL] [Abstract][Full Text] [Related]
37. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
[TBL] [Abstract][Full Text] [Related]
38. Differential time courses of exogenous 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and its metabolite MPP+ in the rat striatum and nucleus accumbens measured using in vivo voltammetry.
Nakazato T; Akiyama A
Brain Res; 1998 Nov; 812(1-2):150-6. PubMed ID: 9813295
[TBL] [Abstract][Full Text] [Related]
39. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
Heikkila RE; Hwang J; Ofori S; Geller HM; Nicklas WJ
J Neurochem; 1990 Mar; 54(3):743-50. PubMed ID: 2303810
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies.
Marongiu ME; Piccardi MP; Bernardi F; Corsini GU; Del Zompo M
Neurosci Lett; 1988 Dec; 94(3):349-54. PubMed ID: 3264604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]